Archive
2021, Volume 5
2020, Volume 4
2019, Volume 3
2018, Volume 2
2017, Volume 1




Volume 4, Issue 2, December 2020, Page: 81-84
Cancer of the Penis: Clinical Features and Therapeutic Modalities in Senegalese Hospitals
Amath Thiam, Urology-Andrology Department, Aristide Le Dantec Hospital, Dakar, Senegal
Alioune Sarr, Urology-Andrology Department, Aristide Le Dantec Hospital, Dakar, Senegal
Ousmane Sow, Urology-Andrology Department, Aristide Le Dantec Hospital, Dakar, Senegal
Ndeye Aïssatou Bagayogo, Urology-Andrology Department, Aristide Le Dantec Hospital, Dakar, Senegal
Modou Ndiaye, Urology-Andrology Department, Aristide Le Dantec Hospital, Dakar, Senegal
Babacar Sine, Urology-Andrology Department, Aristide Le Dantec Hospital, Dakar, Senegal
Cyrille Ze Ondo, Urology-Andrology Department, Aristide Le Dantec Hospital, Dakar, Senegal
Abdoulaye Ndiath, Urology-Andrology Department, Aristide Le Dantec Hospital, Dakar, Senegal
El Hadji Malick Diaw, Urology-Andrology Department, Aristide Le Dantec Hospital, Dakar, Senegal
Yaya Sow, Urology-Andrology Department, Aristide Le Dantec Hospital, Dakar, Senegal
Babacar Diao, Urology-Andrology Department, Aristide Le Dantec Hospital, Dakar, Senegal
Alain Khassim Ndoye, Urology-Andrology Department, Aristide Le Dantec Hospital, Dakar, Senegal
Received: Oct. 14, 2020;       Accepted: Oct. 23, 2020;       Published: Nov. 4, 2020
DOI: 10.11648/j.ijcu.20200402.21      View  140      Downloads  43
Abstract
Background: Penile cancer is a rare malignancy in Senegal. This rarity is probably related to the fact that circumcision, which has a protective effect, is a common practice in childhood. Some of the known risk factors include uncircumcised status, chronic inflammatory conditions, and a history of condyloma acuminata, smoking, and possibly human papillomavirus exposure. It is a pathology in adults with a maximum incidence after the age of 50. In our practice penile cancer is most often diagnosed at an advanced stage or only a radical and mutilating treatment may be proposed. Aims: To describe the clinical and therapeutic features of penis cancer in Senegal. Patients and methods: we carried out a retrospective, descriptive, bicentric study, collecting the records of patients with penis cancer in the Urology-Andrology department of the Aristide Le Dantec University hospital and the military hospital of Ouakam between January 2010 and December 2019. Results: fourteen cases of penile cancer were diagnosed. The mean age was 53.2 years with extremes of 29 and 84 years, the average consultation time was 21 months. All patients were circumcised in childhood. The tumor was limited to the glans in 2 cases and involved the entire penis in 5 cases. Six patients had bilateral inguinal adenopathies. The histological type was squamous cell carcinoma in all cases with a predominance of grade 2 (8 cases). Patients were classified as cT3 (7 cases), cT2 (5 cases), cT4 (1 case) and cT1 (1 case). Treatment consisted of partial amputation of the penis (5 cases), emasculation and perineal urethrostomy (4 cases) total amputation and perineal urethrostomy (2 cases). Three patients had refused total penis amputation. The average length of follow-up was 26 months (4 and 72 months), 3 lymph nodes recurrences and 2 local recurrences were observed. Two patients died among the operated patients. Conclusion: Cancer of the penis is rare in Senegal. The delay in diagnosis explains the frequency of advanced forms which can only be treated by radical surgery.
Keywords
Penile Cancer, Diagnostic Delay, Penile Amputation
To cite this article
Amath Thiam, Alioune Sarr, Ousmane Sow, Ndeye Aïssatou Bagayogo, Modou Ndiaye, Babacar Sine, Cyrille Ze Ondo, Abdoulaye Ndiath, El Hadji Malick Diaw, Yaya Sow, Babacar Diao, Alain Khassim Ndoye, Cancer of the Penis: Clinical Features and Therapeutic Modalities in Senegalese Hospitals, International Journal of Clinical Urology. Vol. 4, No. 2, 2020, pp. 81-84. doi: 10.11648/j.ijcu.20200402.21
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Y. Sow, A. Thiam, B. Fall, M. Coulibali, A. Sarr, B. Diao et al. Cancer du pénis au Sénégal: aspects cliniques et thérapeutiques. Andrologie 2012; 22: 102-107.
[2]
Gueye S. M., Diagne B. A, Ba M, Sylla C, Mensah A. Le cancer de la verge: aspects épidémiologiques et problèmes thérapeutiques au Sénégal. Med Afr Noire 1992; 39: 8–9.
[3]
Figueiroa M N, Menezes M L N, Tavares L N, Maciel A F F, Gomes L. Profile of patients with penile neoplasms who have undergone penectomy. International Archive of Medecine 2017; 10: 223.
[4]
Magoha G A O, Ngumi Z W W. Cancer of the penis at Kenyatta National Hospital. East Afr Med J. 2000; 77: 526–30.
[5]
Chalya PL, Rambau PF, Masalu N, Simbila S. Ten-year surgical experiences with penile cancer at a tertiary care hospital in northwestern Tanzania: a retrospective study of 236 patients. World Journal of Surgical Oncology 2015; 13: 71.
[6]
Ficarra V, Mofferdine A, Malossini G, Mobilio G. Comparaison de la qualité de vie des patients traités pour cancer épidermoïde de la verge par chirurgie ou radiothérapie. Prog Urol 1999; 9: 715-720.
[7]
Rozan R, Albuisson E, Giraud B, Boiteux J P, Dauplat J. Epithéliomas de la verge traités par chirurgie. Prog Urol 1996; 6: 926-935.
[8]
Luciano A F, Aguinaldo C N, Mario R, Stenio C. Z, Sampaio F J. B, Glina S. Epidemiologic Study on Penile Cancer in Brazil. International Braz J Urol 2008; 34 (5): 587-593.
[9]
Sow M, Nkegoum B, Ama Moor VG, et al Les tumeurs du pénis au Cameroun: aspects épidémiologiques, cliniques, anatomo-pathologiques et thérapeutiques. Ann Pathol 2006; 26: 299–301.
[10]
Maden C, Baruah IK. Carcinogenic action of human smegma. Arch Pathol 1963; 75: 414-420.
[11]
Maden C, Sherman KJ, Beckman AM et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst 1993; 85: 19-24.
[12]
Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge for the developing world. Lancet Oncol 2004; 5: 240-7.
[13]
Cornu JN, Comparat E, Renard-Panna R, et al. Prise en charge carcinologique des cancers du pénis. Expérience d’un centre. Prog Urol 2007; 17: 1347–50.
[14]
Burgers JK, Badalament RA, Drago JR. Penile cancer: clinical presentation, diagnosis, and staging. Urol Clin North Am 1992; 19: 247-256.
[15]
Nam JK, Lee DH, Park SW, Kam SC et al. Clinicopathologic characteristics and treatment outcomes of penile cancer. Wold J Mens Health 2017; 35 (1): 28-33.
[16]
Iborra F, Neuzillet Y, Méjean A, Lebret T. Métastase des cancers du pénis. Prog Urol 2008; 18 (Suppl 7): S 392–5.
[17]
Rigaud J. Prise en charge des cancers du pénis. Prog Urol 2014; 13: 1238-42.
[18]
Ornellas AA, Seixas AL, Marota A, Wisnescky A, Campos F, De Moraes JR. Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol. 1994; 151: 1244-9.
[19]
Leijte JA, Hughes B, Graafland NM, et al. Two-center evaluation of dynamic sentinel node biopsy for squamous cell carcinoma of the penis. J Clin Oncol 2009; 27: 3325-9.
[20]
Sadeghi R, Gholami H, Zakavi SR, Kakhki VR, Tabasi KT, Horenblas S. Accuracy of sentinel lymph node biopsy for inguinal lymph node staging of penile squamous cell carcinoma: systematic review and meta- analysis of the literature. J Urol 2012; 187: 25-31.
Browse journals by subject